We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+6.59%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.38B
AUM Growth
+$132M
Cap. Flow
+$91.6M
Cap. Flow %
6.65%
Top 10 Hldgs %
28.56%
Holding
1,934
New
622
Increased
464
Reduced
326
Closed
465

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Communication Services 8.62%
3 Healthcare 8.45%
4 Financials 8.14%
5 Consumer Discretionary 5.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAB icon
1201
Standard BioTools
LAB
$314M
$28K ﹤0.01%
4,711
+1,939
+70% +$12.7K
MSB
1202
Mesabi Trust
MSB
$306M
$28K ﹤0.01%
1,068
PLPC icon
1203
Preformed Line Products
PLPC
$2.28B
$28K ﹤0.01%
+435
New +$30.6K
SAVE
1204
DELISTED
Spirit Airlines, Inc.
SAVE
$28K ﹤0.01%
754
+431
+133% +$18.1K
ARA
1205
DELISTED
American Renal Associates Holdings, Inc
ARA
$28K ﹤0.01%
1,467
-3,433
-70% -$67.7K
TSLF
1206
DELISTED
THL CREDIT SENIOR LOAN FUND
TSLF
$28K ﹤0.01%
1,614
-300
-16% -$5.08K
CSS
1207
DELISTED
CSS Industries, Inc.
CSS
$28K ﹤0.01%
+1,585
New +$35.4K
BEL
1208
CALL
DELISTED
Belmond Ltd.
BEL
$28K ﹤0.01%
+2,500
New +$30.7K
ALE
1209
DELISTED
Allete
ALE
$27K ﹤0.01%
+376
New +$26.6K
CROX icon
1210
Crocs
CROX
$6.55B
$27K ﹤0.01%
+1,645
New +$22.8K
FXH icon
1211
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
$27K ﹤0.01%
385
+128
+50% +$9.23K
KPTI icon
1212
CALL
Karyopharm Therapeutics
KPTI
$48M
$27K ﹤0.01%
+133
New +$26.5K
OSK icon
1213
Oshkosh
OSK
$9.59B
$27K ﹤0.01%
350
-700
-67% -$59.7K
WMB icon
1214
Williams Companies
WMB
$86.1B
$27K ﹤0.01%
1,095
-263
-19% -$7.76K
NCZ
1215
Virtus Convertible & Income Fund II
NCZ
$301M
$26K ﹤0.01%
1,096
-29
-3% -$711
RICK icon
1216
RCI Hospitality Holdings
RICK
$215M
$26K ﹤0.01%
917
-2,999
-77% -$86.5K
UNFI icon
1217
United Natural Foods
UNFI
$2.85B
$26K ﹤0.01%
+600
New +$27.1K
SPNE
1218
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$26K ﹤0.01%
+2,612
New +$26.8K
NTRI
1219
DELISTED
NutriSystem, Inc.
NTRI
$25K ﹤0.01%
+914
New +$36.4K
ABCD
1220
DELISTED
Cambium Learning Group, Inc.
ABCD
$25K ﹤0.01%
+2,266
New +$17.5K
KBH icon
1221
KB Home
KBH
$3.59B
$24K ﹤0.01%
+858
New +$26.7K
PENN icon
1222
CALL
PENN Entertainment
PENN
$2.71B
$24K ﹤0.01%
900
-5,800
-87% -$168K
SKYW icon
1223
Skywest
SKYW
$4.34B
$24K ﹤0.01%
+445
New +$24.6K
ADVM
1224
DELISTED
Adverum Biotechnologies
ADVM
$23K ﹤0.01%
+400
New +$24.9K
LRMR icon
1225
Larimar Therapeutics
LRMR
$432M
$23K ﹤0.01%
+258
New +$21.9K

Similar funds

Prelude Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Prelude Capital Management held 1,934 positions worth $1.38B, up 11% from $1.25B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Prelude Capital Management deployed $91.6M of net new capital in Q1 2018, opening 622 new positions and adding to 464 existing holdings. Its largest new stake was XL Group Ltd.: 571,194 shares worth $31.6M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Twenty-First Century Fox, Inc. Class B, an estimated $10.5M trimmed.

  • Prelude Capital Management's largest Q1 2018 buy was XL Group Ltd.: 571,194 shares worth $31.6M.
  • Prelude Capital Management added most to NXP Semiconductors in Q1 2018, an estimated $19.7M increase.
  • Prelude Capital Management's biggest Q1 2018 reduction was Twenty-First Century Fox, Inc. Class B, cutting an estimated $10.5M.
  • Prelude Capital Management fully exited Scripps Networks Interactive, Inc Common Class A in Q1 2018, selling an estimated $21.7M.
  • Prelude Capital Management's ten largest holdings make up 29% of its $1.38B portfolio in Q1 2018.
  • Prelude Capital Management opened 622 new positions and closed 465 in Q1 2018.
  • Prelude Capital Management's portfolio value rose 11% quarter-over-quarter to $1.38B.

Based on Prelude Capital Management's 13F filing for Q1 2018, filed 15 May 2018.